Cardinal Health Inc
XBER:CLH

Watchlist Manager
Cardinal Health Inc Logo
Cardinal Health Inc
XBER:CLH
Watchlist
Price: 176.25 EUR Market Closed
Market Cap: €27.7B

Wall St Price Targets

CLH Price Targets Summary
Cardinal Health Inc

Wall Street analysts forecast CLH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLH is 197.32 EUR with a low forecast of 156.22 EUR and a high forecast of 227.35 EUR.

Lowest Forecast
Price Target
156.22 EUR
11% Downside
Average Forecast
Price Target
197.32 EUR
12% Upside
Highest Forecast
Price Target
227.35 EUR
29% Upside
Cardinal Health Inc Competitors:
Price Targets
ADMR
Adaro Minerals Indonesia Tbk PT
30% Upside

Revenue
Forecast

6% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
6% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 4 years is 10%.

Gross Profit
Forecast

5% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
5% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 4 years is 10%.

Operating Income
Forecast

3% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
3% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 4 years is 18%.

Pre-Tax Income
Forecast

2% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-49%
Average Miss
2% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-49%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 2%. The projected CAGR for the next 3 years is 24%.

Net Income
Forecast

3% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-54%
Average Miss
3% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-54%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 4 years is 22%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CLH's stock price target?
Price Target
197.32 EUR

According to Wall Street analysts, the average 1-year price target for CLH is 197.32 EUR with a low forecast of 156.22 EUR and a high forecast of 227.35 EUR.

What is the Revenue forecast for Cardinal Health Inc?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 4 years is 10%.

What is the Gross Profit forecast for Cardinal Health Inc?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 4 years is 10%.

What is the Operating Income forecast for Cardinal Health Inc?
Projected CAGR
18%

Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 4 years is 18%.

What is the Pre-Tax Income forecast for Cardinal Health Inc?
Projected CAGR
24%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 2%. The projected CAGR for the next 3 years is 24%.

What is the Net Income forecast for Cardinal Health Inc?
Projected CAGR
22%

Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 4 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett